Can too many safety warnings overwhelm consumers?

11:20 EDT 21 Jun 2017 | BioPharmaDive

Two FDA experiments will test whether repetition of safety warnings in DTC ads negatively affects consumers’ attention to drug risks.

Original Article: Can too many safety warnings overwhelm consumers?


More From BioPortfolio on "Can too many safety warnings overwhelm consumers?"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...